Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2016 and Operational Progress

Go back to Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2016 and Operational Progress

Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share

June 2, 2016 7:08 AM EDT

Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

... More